SynthesisCancer medicine2023

Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis of randomized clinical trials.

Shoutao Dang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.